Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Huan Meng
University of California Los Angeles, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
WESTWOOD BIOSCIENCE
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Professor Huan Meng is a Multi-Principal Investigator along with Drs. Nel, Donahue and Zink. He is a founder of the company and on the scientific advisory board and a board member.
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
Our research addresses the treatment of pancreatic ductal adenocarcinoma (PDAC), which is frequently incurable and resists cancer drugs due to an impenetrable stroma, blocked vasculature, metabolic inactivation or failure to activate the first line chemo-therapeutic agent, gemcitabine (GEM). While a four-drug regimen with the acronym, FOLFIRINOX, is potentially more efficacious, it is very toxic and can only be used in a small subset of PDAC patients. We have developed a series of mesoporous silica nanocarriers (that resemble hollow glass bubbles with a lipid bilayer coating) to deliver high loads of GEM and the most toxic FOLFIRINOX component, irinotecan, to the PDAC site, with the objective to improve survival outcome based on smart design features that overcome the specific cancer resistance mechanisms.
Filed on August 15, 2017.
Tell us what you know about Huan Meng's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Huan Meng filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Huan Meng | University of California Los Angeles | Conflict of Interest | WESTWOOD BIOSCIENCE | $0 - $4,999 |
Other search results for: “Huan Meng”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Huan Meng | University of California Los Angeles | Financial Disclosure | Westwood Biosciences | |
Huan Meng | University of California Los Angeles | Financial Disclosure | Westwood Biosciences | |
Huan Meng | University of California Los Angeles | Financial Disclosure | Westwood Biosciences | |
Huan Meng | University of California Los Angeles | Financial Disclosure | Westwood Biosciences | |
Huan Meng | University of California Los Angeles | Financial Disclosure | Westwood Bioscience, Inc. |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.